The current generation of antipsychotics all work in a broadly similar way: inhibiting dopamine and serotonin receptors. These therapies leave a lot to be desired, however, with around three quarters of patients having to try multiple treatments and around a quarter eventually deemed non-responders.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,